0001847173-21-000002.txt : 20210303
0001847173-21-000002.hdr.sgml : 20210303
20210303140839
ACCESSION NUMBER: 0001847173-21-000002
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20210303
DATE AS OF CHANGE: 20210303
EFFECTIVENESS DATE: 20210303
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Excision BioTherapeutics Inc
CENTRAL INDEX KEY: 0001847173
IRS NUMBER: 473658697
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-391112
FILM NUMBER: 21708258
BUSINESS ADDRESS:
STREET 1: 988 MARKET STREET, SECOND FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94102
BUSINESS PHONE: (404) 229-1162
MAIL ADDRESS:
STREET 1: 988 MARKET STREET, SECOND FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94102
D
1
primary_doc.xml
X0708
D
LIVE
0001847173
Excision BioTherapeutics Inc
988 MARKET STREET, SECOND FLOOR
SAN FRANCISCO
CA
CALIFORNIA
94102
(404) 229-1162
DELAWARE
None
None
Corporation
true
Daniel
Dornbusch
c/o Excision BioTherapeutics Inc
988 Market Street, Second Floor
San Francisco
CA
CALIFORNIA
94102
Executive Officer
Director
Vasudev
Bailey
c/o Excision BioTherapeutics Inc
988 Market Street, Second Floor
San Francisco
CA
CALIFORNIA
94102
Director
William
Carson
c/o Excision BioTherapeutics Inc
988 Market Street, Second Floor
San Francisco
CA
CALIFORNIA
94102
Director
Ashok
Krishnamurthi
c/o Excision BioTherapeutics Inc
988 Market Street, Second Floor
San Francisco
CA
CALIFORNIA
94102
Director
Biotechnology
Decline to Disclose
- 06b
false
2021-02-16
false
true
true
true
Offering of convertible promissory notes ("Notes") and the underlying shares of equity securities issuable upon conversion of the Notes.
false
1
10500000
10500000
0
false
6
0
0
0
false
Excision BioTherapeutics Inc
/s/ Daniel Dornbusch
Daniel Dornbusch
Chief Executive Officer
2021-03-03